MedTrace Logo

Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee System

NCT03078543 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2026-03-11

No results posted yet for this study

Summary

The ANTHEM™PS Total Knee System is being conducted to demonstrate non-inferiority of 10 year implant survivorship in patients undergoing total knee arthroplasty for osteoarthritis compared to reported literature

Conditions

  • Arthroplasty, Replacement, Knee

Interventions

DEVICE

ANTHEM™ PS Total Knee System implant

The ANTHEM™ PS Total Knee System is a comprehensive system which allows surgeons to address simple to complex knee arthroplasties. The ANTHEM™ PS Total Knee System consists of the following components: * Cobalt-Chrome (Co-Cr) femoral components - Posterior stabilised * Titanium primary tibial components * Posterior-stabilised ultra-high molecular weight polyethylene (UHMWPE) * Polyethylene patella components The resulting product is sufficient to accommodate a wide range of clinical applications.

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Julian Yang · Smith & Nephew Medical (Shanghai) Limited

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-28
Primary Completion
2029-04-30
Completion
2029-04-30
FDA Device
Yes

Countries

  • China
  • Italy
  • South Africa
  • South Korea
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078543 on ClinicalTrials.gov